Studio osservazionale sulla recidiva locale da osteosarcoma ad alto grado

Title

Code

Osteo LR

Type

Osservazionale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366101

emanuela.palmerini@ior.it

Palmerini Emanuela, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Description

Tutti i medici oncologi dell'Osteoncologia sono co-investigator e quindi arruolano pazienti per questo studio.

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio clinico prot. Osteo LR

Monday 20 June 2022, 16:54

PG0009608_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio osservazionale sulla recidiva locale da osteosarcoma ad alto grado

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in